| |
 |
|
| Medical Edge |
|
|
|
Medical Edge Newspaper Column from Mayo Clinic
NEW HORMONE THERAPIES FOR BREAST CANCER PATIENTS
DEAR MAYO CLINIC: I’m a breast cancer survivor and happy to be
here! I’m 72 years old, have had one breast surgically removed and have
been on tamoxifen for nearly three years to prevent recurrence. My doctor
says I have to go off it when I reach the five-year mark — and I’m already
worried about this. I’m scared the cancer will come back. Is there something
else I can try that’s as good as tamoxifen? I know it’s wrong, but some
days worrying about my future robs me of the joy of health I have today.
— Oklahoma City
ANSWER: Yes, promising new hormone therapies exist for women following
surgical or radiation treatment of breast cancer. Tamoxifen has been the
standard therapy for about 20 years in both pre- and postmenopausal breast
cancer patients. Many patients who do well with tamoxifen would like to
take it for longer than five years. Unfortunately, results from clinical
studies testing 10-year use of tamoxifen do not support that decision.
But there is good news: Effective new hormone therapies called aromatase
inhibitors are available for postmenopausal breast cancer patients. Many
are surprised to learn that postmenopausal women still make estrogen,
which promotes the growth of certain kinds of breast cancer. The aromatase
inhibitor stops this estrogen production. (Note: Premenopausal women don’t
have the same treatment choices, because their ovaries are still producing
estrogen.)
Three recent large studies of aromatase inhibitors, conducted at major
medical centers and published between 2002 and 2004, involved about 19,000
postmenopausal women in the United States and Canada with hormone-receptor-positive
breast cancer. From these studies, three new basic treatment scenarios
have emerged:
— taking tamoxifen for five years, then considering taking an aromatase
inhibitor for an additional time;
— taking tamoxifen for two or three years, and then switching to an aromatase
inhibitor for the remainder of a five-year treatment cycle;
— taking an aromatase inhibitor exclusively for five years.
Results of the three clinical studies showed that aromatase inhibitors,
either taken alone or following tamoxifen, were effective therapy. The
advantages of aromatase inhibitors are twofold: They may be more effective
than tamoxifen in preventing recurrence, and there is a lower risk of
blood clots and uterine cancer with their use. However, all three studies
reported joint and muscle pains as side effects, which were bothersome
to about 5 to 10 percent of patients taking aromatase inhibitors. Another
side effect reported in all three studies is increased risk for osteoporosis.
It is not clear whether treatment with calcium, vitamin D or other drugs
can prevent this.
Cost is another issue. Aromatase inhibitors cost $200 to $300 per month,
compared to $40 to $100 per month for tamoxifen.
As you can see, the treatment for postmenopausal breast cancer patients
has changed profoundly in recent years and no doubt will continue to change.
By all means, discuss aromatase inhibitor treatment with your physician.
James Ingle, M.D., and Charles Loprinzi, M.D., Medical Oncology;
Mayo Clinic, Rochester, Minn.
Additional Resources:
Mayo Clinic Oncology
Appointment
Information
More
Information on Breast Cancer
SAND-PLAY SAFETY
Medical researchers remind parents to supervise children playing in sand.
Two instances in which children were killed after being buried in sand
emphasize the point that beaches, sandboxes, sand piles and natural play
areas may be dangerous.
A recent research article in Mayo Clinic Proceedings examined two accidental
deaths of boys who were trapped under sand. One 10-year-old died when
the tunnel he was digging in his sandbox collapsed on him. He was buried
for about 10 minutes before he was pulled from the sand. In the second
case, a 10-year-old boy was buried in wet sand at a construction site
after a 30-foot pile of sand collapsed on him. In both cases, the weight
of the sand compressed the child’s chest and prevented proper breathing.
Doctors say that greater awareness by public health personnel, safety
officials and parents may help prevent such potentially fatal accidents.
Additional Resources:
Safe
Play
- - -
Medical Edge from Mayo Clinic is an educational resource and doesn’t
replace regular medical care. To e-mail a question, go to www.mayoclinic.org,
or write: Medical Edge from Mayo Clinic, c/o TMS, 2225 Kenmore Ave., Suite
114, Buffalo, N.Y., 14207. For health information, visit www.mayoclinic.com.
© 2004 TRIBUNE MEDIA SERVICES, INC.
|
|